At N1 Healthcare, our mission is to transform healthcare delivery by providing in-depth, personalized health insights that empower individuals to take proactive steps towards enhancing their well-being and longevity. We strive to be at the forefront of the personalized healthcare revolution, setting new standards for precision and care in the industry.
We envision a world where healthcare is not just reactive but proactive, tailored to each individual's unique genetic makeup, lifestyle, and health history. Our vision is to make personalized healthcare accessible to those who value a deeper understanding of their health and seek to actively manage it for a longer, healthier life.
We differentiate ourselves by offering a service that goes beyond the traditional scope of medical care. Our comprehensive health reports are meticulously crafted, encompassing everything from a thorough analysis of family medical history and DNA sequencing to a detailed examination of lifestyle, nutrition, and all past and present medical tests. This holistic approach ensures a complete understanding of our clients' health profiles.
Our strength lies in our diverse team of highly skilled technical writers and specialized clinicians from around the world. This team brings together a wealth of expertise, ensuring that each health report is not only comprehensive but also enriched with insights from various medical perspectives and practices.
At N1 Healthcare, we are committed to upholding the highest standards of quality and precision in every aspect of our service. We continuously update our methodologies and practices to stay abreast of the latest advancements in healthcare and medical technology.
The core of our service is empowering our clients with knowledge. We believe that informed clients are better equipped to make decisions about their healthcare and lifestyle, leading to improved health outcomes and enhanced quality of life.
Nick Sireau, PhD, is co-founder of N1 Healthcare, and brings a wealth of experience and a deep passion for healthcare innovation. With a background in medical sciences and a strong inclination towards research and development, Nick has always been at the forefront of adopting new approaches to healthcare. Nick is the CEO and Chair of Trustees at the AKU Society, a patient group that helps people with AKU, a rare genetic disease affecting both his children. The AKU Society and Nick are the winners of the 2021 Members Award by EURORDIS (the European Organisation of Rare Diseases) because of their work on successfully developing a new treatment for AKU. Nick is co-founder and Chair of Beacon, an organisation that helps all rare disease patient groups. He is the editor of ‘Rare Diseases: Challenges and Opportunities for Social Entrepreneurs’ (Greenleaf 2013) and of the 'Patient Group Handbook: A Practical Guide for Research and Drug Development' (Beacon 2016). Nick is cofounder and Chair of Orchard OCD, a medical charity that funds research into obsessive-compulsive disorder (OCD), a common yet debilitating mental health condition. He is also co-founder of Sirgartan Therapeutics, a biotech that focuses on new treatments for OCD, and of Sireau Labs, a biotech that is developing mRNA therapy for AKU and other rare genetic diseases. Nick has a BA in history and economics from Oxford University, an MSc in management studies from the Lyon Graduate School of Business, an MA in Journalism Studies from Westminster University and a PhD in social psychology from City University. He is a fellow of the Ashoka Fellowship of Social Entrepreneurs.
Jean-Yves Sireau is the visionary entrepreneur behind N1 Healthcare. His journey in the business world began at a young age, marked by a spirit of innovation and a penchant for strategic thinking. Before co-founding N1 Healthcare, Jean-Yves had already established himself as a successful entrepreneur. Jean-Yves is the founder and CEO of Deriv, an online trading broker founded in 1999. The company has become one of the world’s largest online brokers, offering a wide range of CFD and other derivative contracts on forex, stocks, and derived indices to over a million clients worldwide. Now a global company, Deriv Group has more than 1,300 employees across 20 offices worldwide.
Jean-Yves's inspiration for N1 Healthcare stemmed from his keen interest in personalized medicine and his belief in the transformative power of technology in healthcare. He recognized the gap in tailored healthcare services for discerning individuals and saw an opportunity to bring his entrepreneurial vision to this niche sector. His goal was to create a service that not only catered to the unique health needs of each client but also empowered them with comprehensive, data-driven insights for better health management.